Search results
Half of Japan’s Covid-19 experts faced threats, abuse by ‘anti-vaxxers’: survey
South China Morning Post· 11 hours agoDr Shigeru Omi, a former regional director of the World Health Organization and chairman of the...
Slovak assassination attempt and Harrison Butker speech backlash: Morning Rundown
NBC News via Yahoo News· 24 hours agoBut Secretary of State Antony Blinken’s attempt to rouse Ukrainian spirits with a performance of...
Anti-vaccination activists work to discredit vaccinations
The Lake County Record-Bee· 2 days agoF. Kennedy Jr., who was working to discredit vaccinations long before the COVID-19 pandemic, even as...
Why SDBOR won't share how many employees were told to change their email signatures
Argus Leader via Yahoo News· 1 day agoThe idea that providing the raw number of employees affected by the change would constitute personal information “seems pretty far-fetched," experts said.
Enrichment only for the rich? How school segregation continues to divide students by income
The Courier Journal via Yahoo News· 1 day agoBoard of Education, the landmark U.S. Supreme Court case that determined school segregation violated...
Millennials Coming To A Golf Course Community Near You
Benzinga via Yahoo Finance· 18 hours agoIt seems like just yesterday that Baby Boomers and Gen Xers were complaining about millennials'...
Q1 2024 Grab Holdings Ltd Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 20 hours agoThe program was born in 2021 during the COVID pandemic and since then, has already benefited 26,000 MSMEs in 9 cities nationwide. As highlighted in our fourth quarter 2023 ...
Why GM Remains Committed to China Despite Losing Money
Autoweek via Yahoo News· 18 hours agoThat was a 16.2% market share of 24.72 million vehicles for the year. As the COVID pandemic emerged,...
Variety of epidemics threaten state and nation
The Lake County Record-Bee· 2 days agoKennedy Jr., who was working to discredit vaccinations long before the COVID-19 pandemic, even as he denied being an anti-vaxxer. Hey Junior, ever heard...
More Support for Tenecteplase in Ischemic Stroke
Medscape· 8 hours agoThe bolus thrombolytic agent, tenecteplase, narrowly failed to show non-inferiority to alteplase in the TASTE clinical trial within 4.5 hours of symptom...
